Cargando…
miR‐505 inhibits proliferation of osteosarcoma via HMGB1
Osteosarcoma is a malignant bone tumor, and clinically detectable metastases can be detected in ~ 15–20% of patients when they seek medical advice; patients with metastatic disease have extremely poor prognosis. Here, we examined the involvement of the microRNA miR‐505 in osteosarcoma. Eighty‐four p...
Autores principales: | Li, Guangzhang, Liu, Fajing, Miao, Jun, Hu, Yongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327918/ https://www.ncbi.nlm.nih.gov/pubmed/32348630 http://dx.doi.org/10.1002/2211-5463.12868 |
Ejemplares similares
-
Inhibition of miR-9 decreases osteosarcoma cell proliferation
por: Gang, Wu, et al.
Publicado: (2020) -
LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia
por: Ke, Shandong, et al.
Publicado: (2019) -
MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R
por: Ren, Liang, et al.
Publicado: (2019) -
The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2
por: Lin, Haopeng, et al.
Publicado: (2019) -
miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019)